Global HAE Treatments Market Growth 2026-2032
The global HAE Treatments market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
HAE (Hereditary Angioedema) treatments aim to manage and prevent the unpredictable and potentially life-threatening swelling episodes associated with the condition. These treatments target the underlying cause: a deficiency or dysfunction of C1 esterase inhibitor (C1-INH), which leads to uncontrolled activation of the complement and kallikrein-kinin systems, resulting in swelling. There are three main categories of HAE treatments: C1-INH replacement therapies (e.g., Berinert, Haegarda) that restore functional C1-INH levels; kallikrein inhibitors (e.g., Ecallantide) that block the enzyme responsible for bradykinin production; and bradykinin B2 receptor antagonists (e.g., Icatibant) that prevent bradykinin from causing vascular permeability and swelling.
United States market for HAE Treatments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for HAE Treatments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for HAE Treatments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key HAE Treatments players cover Takeda Pharmaceuticals, BioCryst Pharmaceuticals, CSL Behring, Pharming Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?HAE Treatments Industry Forecast? looks at past sales and reviews total world HAE Treatments sales in 2025, providing a comprehensive analysis by region and market sector of projected HAE Treatments sales for 2026 through 2032. With HAE Treatments sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HAE Treatments industry.
This Insight Report provides a comprehensive analysis of the global HAE Treatments landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HAE Treatments portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global HAE Treatments market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HAE Treatments and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HAE Treatments.
This report presents a comprehensive overview, market shares, and growth opportunities of HAE Treatments market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global HAE Treatments market?
What factors are driving HAE Treatments market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do HAE Treatments market opportunities vary by end market size?
How does HAE Treatments break out by Type, by Application?
HAE (Hereditary Angioedema) treatments aim to manage and prevent the unpredictable and potentially life-threatening swelling episodes associated with the condition. These treatments target the underlying cause: a deficiency or dysfunction of C1 esterase inhibitor (C1-INH), which leads to uncontrolled activation of the complement and kallikrein-kinin systems, resulting in swelling. There are three main categories of HAE treatments: C1-INH replacement therapies (e.g., Berinert, Haegarda) that restore functional C1-INH levels; kallikrein inhibitors (e.g., Ecallantide) that block the enzyme responsible for bradykinin production; and bradykinin B2 receptor antagonists (e.g., Icatibant) that prevent bradykinin from causing vascular permeability and swelling.
United States market for HAE Treatments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for HAE Treatments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for HAE Treatments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key HAE Treatments players cover Takeda Pharmaceuticals, BioCryst Pharmaceuticals, CSL Behring, Pharming Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?HAE Treatments Industry Forecast? looks at past sales and reviews total world HAE Treatments sales in 2025, providing a comprehensive analysis by region and market sector of projected HAE Treatments sales for 2026 through 2032. With HAE Treatments sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HAE Treatments industry.
This Insight Report provides a comprehensive analysis of the global HAE Treatments landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HAE Treatments portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global HAE Treatments market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HAE Treatments and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HAE Treatments.
This report presents a comprehensive overview, market shares, and growth opportunities of HAE Treatments market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- C1 Esterase Inhibitors
- Kallikrein Inhibitors
- Bradykinin Receptor Antagonist
- Hospital and Clinic
- Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda Pharmaceuticals
- BioCryst Pharmaceuticals
- CSL Behring
- Pharming Healthcare
What is the 10-year outlook for the global HAE Treatments market?
What factors are driving HAE Treatments market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do HAE Treatments market opportunities vary by end market size?
How does HAE Treatments break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HAE Treatments Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for HAE Treatments by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for HAE Treatments by Country/Region, 2021, 2025 & 2032
2.2 HAE Treatments Segment by Type
2.2.1 C1 Esterase Inhibitors
2.2.2 Kallikrein Inhibitors
2.2.3 Bradykinin Receptor Antagonist
2.2.4 HAE Treatments Sales by Type
2.2.4.1 Global HAE Treatments Sales Market Share by Type (2021-2026)
2.2.4.2 Global HAE Treatments Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global HAE Treatments Sale Price by Type (2021-2026)
2.3 HAE Treatments Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Pharmacy
2.3.3 Other
2.3.4 HAE Treatments Sales by Application
2.3.4.1 Global HAE Treatments Sale Market Share by Application (2021-2026)
2.3.4.2 Global HAE Treatments Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global HAE Treatments Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global HAE Treatments Breakdown Data by Company
3.1.1 Global HAE Treatments Annual Sales by Company (2021-2026)
3.1.2 Global HAE Treatments Sales Market Share by Company (2021-2026)
3.2 Global HAE Treatments Annual Revenue by Company (2021-2026)
3.2.1 Global HAE Treatments Revenue by Company (2021-2026)
3.2.2 Global HAE Treatments Revenue Market Share by Company (2021-2026)
3.3 Global HAE Treatments Sale Price by Company
3.4 Key Manufacturers HAE Treatments Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HAE Treatments Product Location Distribution
3.4.2 Players HAE Treatments Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HAE TREATMENTS BY GEOGRAPHIC REGION
4.1 World Historic HAE Treatments Market Size by Geographic Region (2021-2026)
4.1.1 Global HAE Treatments Annual Sales by Geographic Region (2021-2026)
4.1.2 Global HAE Treatments Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic HAE Treatments Market Size by Country/Region (2021-2026)
4.2.1 Global HAE Treatments Annual Sales by Country/Region (2021-2026)
4.2.2 Global HAE Treatments Annual Revenue by Country/Region (2021-2026)
4.3 Americas HAE Treatments Sales Growth
4.4 APAC HAE Treatments Sales Growth
4.5 Europe HAE Treatments Sales Growth
4.6 Middle East & Africa HAE Treatments Sales Growth
5 AMERICAS
5.1 Americas HAE Treatments Sales by Country
5.1.1 Americas HAE Treatments Sales by Country (2021-2026)
5.1.2 Americas HAE Treatments Revenue by Country (2021-2026)
5.2 Americas HAE Treatments Sales by Type (2021-2026)
5.3 Americas HAE Treatments Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HAE Treatments Sales by Region
6.1.1 APAC HAE Treatments Sales by Region (2021-2026)
6.1.2 APAC HAE Treatments Revenue by Region (2021-2026)
6.2 APAC HAE Treatments Sales by Type (2021-2026)
6.3 APAC HAE Treatments Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe HAE Treatments by Country
7.1.1 Europe HAE Treatments Sales by Country (2021-2026)
7.1.2 Europe HAE Treatments Revenue by Country (2021-2026)
7.2 Europe HAE Treatments Sales by Type (2021-2026)
7.3 Europe HAE Treatments Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HAE Treatments by Country
8.1.1 Middle East & Africa HAE Treatments Sales by Country (2021-2026)
8.1.2 Middle East & Africa HAE Treatments Revenue by Country (2021-2026)
8.2 Middle East & Africa HAE Treatments Sales by Type (2021-2026)
8.3 Middle East & Africa HAE Treatments Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HAE Treatments
10.3 Manufacturing Process Analysis of HAE Treatments
10.4 Industry Chain Structure of HAE Treatments
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HAE Treatments Distributors
11.3 HAE Treatments Customer
12 WORLD FORECAST REVIEW FOR HAE TREATMENTS BY GEOGRAPHIC REGION
12.1 Global HAE Treatments Market Size Forecast by Region
12.1.1 Global HAE Treatments Forecast by Region (2027-2032)
12.1.2 Global HAE Treatments Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global HAE Treatments Forecast by Type (2027-2032)
12.7 Global HAE Treatments Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceuticals
13.1.1 Takeda Pharmaceuticals Company Information
13.1.2 Takeda Pharmaceuticals HAE Treatments Product Portfolios and Specifications
13.1.3 Takeda Pharmaceuticals HAE Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Pharmaceuticals Main Business Overview
13.1.5 Takeda Pharmaceuticals Latest Developments
13.2 BioCryst Pharmaceuticals
13.2.1 BioCryst Pharmaceuticals Company Information
13.2.2 BioCryst Pharmaceuticals HAE Treatments Product Portfolios and Specifications
13.2.3 BioCryst Pharmaceuticals HAE Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BioCryst Pharmaceuticals Main Business Overview
13.2.5 BioCryst Pharmaceuticals Latest Developments
13.3 CSL Behring
13.3.1 CSL Behring Company Information
13.3.2 CSL Behring HAE Treatments Product Portfolios and Specifications
13.3.3 CSL Behring HAE Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CSL Behring Main Business Overview
13.3.5 CSL Behring Latest Developments
13.4 Pharming Healthcare
13.4.1 Pharming Healthcare Company Information
13.4.2 Pharming Healthcare HAE Treatments Product Portfolios and Specifications
13.4.3 Pharming Healthcare HAE Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pharming Healthcare Main Business Overview
13.4.5 Pharming Healthcare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HAE Treatments Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for HAE Treatments by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for HAE Treatments by Country/Region, 2021, 2025 & 2032
2.2 HAE Treatments Segment by Type
2.2.1 C1 Esterase Inhibitors
2.2.2 Kallikrein Inhibitors
2.2.3 Bradykinin Receptor Antagonist
2.2.4 HAE Treatments Sales by Type
2.2.4.1 Global HAE Treatments Sales Market Share by Type (2021-2026)
2.2.4.2 Global HAE Treatments Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global HAE Treatments Sale Price by Type (2021-2026)
2.3 HAE Treatments Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Pharmacy
2.3.3 Other
2.3.4 HAE Treatments Sales by Application
2.3.4.1 Global HAE Treatments Sale Market Share by Application (2021-2026)
2.3.4.2 Global HAE Treatments Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global HAE Treatments Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global HAE Treatments Breakdown Data by Company
3.1.1 Global HAE Treatments Annual Sales by Company (2021-2026)
3.1.2 Global HAE Treatments Sales Market Share by Company (2021-2026)
3.2 Global HAE Treatments Annual Revenue by Company (2021-2026)
3.2.1 Global HAE Treatments Revenue by Company (2021-2026)
3.2.2 Global HAE Treatments Revenue Market Share by Company (2021-2026)
3.3 Global HAE Treatments Sale Price by Company
3.4 Key Manufacturers HAE Treatments Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HAE Treatments Product Location Distribution
3.4.2 Players HAE Treatments Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HAE TREATMENTS BY GEOGRAPHIC REGION
4.1 World Historic HAE Treatments Market Size by Geographic Region (2021-2026)
4.1.1 Global HAE Treatments Annual Sales by Geographic Region (2021-2026)
4.1.2 Global HAE Treatments Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic HAE Treatments Market Size by Country/Region (2021-2026)
4.2.1 Global HAE Treatments Annual Sales by Country/Region (2021-2026)
4.2.2 Global HAE Treatments Annual Revenue by Country/Region (2021-2026)
4.3 Americas HAE Treatments Sales Growth
4.4 APAC HAE Treatments Sales Growth
4.5 Europe HAE Treatments Sales Growth
4.6 Middle East & Africa HAE Treatments Sales Growth
5 AMERICAS
5.1 Americas HAE Treatments Sales by Country
5.1.1 Americas HAE Treatments Sales by Country (2021-2026)
5.1.2 Americas HAE Treatments Revenue by Country (2021-2026)
5.2 Americas HAE Treatments Sales by Type (2021-2026)
5.3 Americas HAE Treatments Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HAE Treatments Sales by Region
6.1.1 APAC HAE Treatments Sales by Region (2021-2026)
6.1.2 APAC HAE Treatments Revenue by Region (2021-2026)
6.2 APAC HAE Treatments Sales by Type (2021-2026)
6.3 APAC HAE Treatments Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe HAE Treatments by Country
7.1.1 Europe HAE Treatments Sales by Country (2021-2026)
7.1.2 Europe HAE Treatments Revenue by Country (2021-2026)
7.2 Europe HAE Treatments Sales by Type (2021-2026)
7.3 Europe HAE Treatments Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HAE Treatments by Country
8.1.1 Middle East & Africa HAE Treatments Sales by Country (2021-2026)
8.1.2 Middle East & Africa HAE Treatments Revenue by Country (2021-2026)
8.2 Middle East & Africa HAE Treatments Sales by Type (2021-2026)
8.3 Middle East & Africa HAE Treatments Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HAE Treatments
10.3 Manufacturing Process Analysis of HAE Treatments
10.4 Industry Chain Structure of HAE Treatments
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HAE Treatments Distributors
11.3 HAE Treatments Customer
12 WORLD FORECAST REVIEW FOR HAE TREATMENTS BY GEOGRAPHIC REGION
12.1 Global HAE Treatments Market Size Forecast by Region
12.1.1 Global HAE Treatments Forecast by Region (2027-2032)
12.1.2 Global HAE Treatments Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global HAE Treatments Forecast by Type (2027-2032)
12.7 Global HAE Treatments Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceuticals
13.1.1 Takeda Pharmaceuticals Company Information
13.1.2 Takeda Pharmaceuticals HAE Treatments Product Portfolios and Specifications
13.1.3 Takeda Pharmaceuticals HAE Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Pharmaceuticals Main Business Overview
13.1.5 Takeda Pharmaceuticals Latest Developments
13.2 BioCryst Pharmaceuticals
13.2.1 BioCryst Pharmaceuticals Company Information
13.2.2 BioCryst Pharmaceuticals HAE Treatments Product Portfolios and Specifications
13.2.3 BioCryst Pharmaceuticals HAE Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BioCryst Pharmaceuticals Main Business Overview
13.2.5 BioCryst Pharmaceuticals Latest Developments
13.3 CSL Behring
13.3.1 CSL Behring Company Information
13.3.2 CSL Behring HAE Treatments Product Portfolios and Specifications
13.3.3 CSL Behring HAE Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CSL Behring Main Business Overview
13.3.5 CSL Behring Latest Developments
13.4 Pharming Healthcare
13.4.1 Pharming Healthcare Company Information
13.4.2 Pharming Healthcare HAE Treatments Product Portfolios and Specifications
13.4.3 Pharming Healthcare HAE Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pharming Healthcare Main Business Overview
13.4.5 Pharming Healthcare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. HAE Treatments Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. HAE Treatments Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of C1 Esterase Inhibitors
Table 4. Major Players of Kallikrein Inhibitors
Table 5. Major Players of Bradykinin Receptor Antagonist
Table 6. Global HAE Treatments Sales by Type (2021-2026) & (K Units)
Table 7. Global HAE Treatments Sales Market Share by Type (2021-2026)
Table 8. Global HAE Treatments Revenue by Type (2021-2026) & ($ million)
Table 9. Global HAE Treatments Revenue Market Share by Type (2021-2026)
Table 10. Global HAE Treatments Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global HAE Treatments Sale by Application (2021-2026) & (K Units)
Table 12. Global HAE Treatments Sale Market Share by Application (2021-2026)
Table 13. Global HAE Treatments Revenue by Application (2021-2026) & ($ million)
Table 14. Global HAE Treatments Revenue Market Share by Application (2021-2026)
Table 15. Global HAE Treatments Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global HAE Treatments Sales by Company (2021-2026) & (K Units)
Table 17. Global HAE Treatments Sales Market Share by Company (2021-2026)
Table 18. Global HAE Treatments Revenue by Company (2021-2026) & ($ millions)
Table 19. Global HAE Treatments Revenue Market Share by Company (2021-2026)
Table 20. Global HAE Treatments Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers HAE Treatments Producing Area Distribution and Sales Area
Table 22. Players HAE Treatments Products Offered
Table 23. HAE Treatments Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global HAE Treatments Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global HAE Treatments Sales Market Share Geographic Region (2021-2026)
Table 28. Global HAE Treatments Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global HAE Treatments Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global HAE Treatments Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global HAE Treatments Sales Market Share by Country/Region (2021-2026)
Table 32. Global HAE Treatments Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global HAE Treatments Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas HAE Treatments Sales by Country (2021-2026) & (K Units)
Table 35. Americas HAE Treatments Sales Market Share by Country (2021-2026)
Table 36. Americas HAE Treatments Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas HAE Treatments Sales by Type (2021-2026) & (K Units)
Table 38. Americas HAE Treatments Sales by Application (2021-2026) & (K Units)
Table 39. APAC HAE Treatments Sales by Region (2021-2026) & (K Units)
Table 40. APAC HAE Treatments Sales Market Share by Region (2021-2026)
Table 41. APAC HAE Treatments Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC HAE Treatments Sales by Type (2021-2026) & (K Units)
Table 43. APAC HAE Treatments Sales by Application (2021-2026) & (K Units)
Table 44. Europe HAE Treatments Sales by Country (2021-2026) & (K Units)
Table 45. Europe HAE Treatments Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe HAE Treatments Sales by Type (2021-2026) & (K Units)
Table 47. Europe HAE Treatments Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa HAE Treatments Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa HAE Treatments Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa HAE Treatments Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa HAE Treatments Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of HAE Treatments
Table 53. Key Market Challenges & Risks of HAE Treatments
Table 54. Key Industry Trends of HAE Treatments
Table 55. HAE Treatments Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. HAE Treatments Distributors List
Table 58. HAE Treatments Customer List
Table 59. Global HAE Treatments Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global HAE Treatments Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas HAE Treatments Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas HAE Treatments Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC HAE Treatments Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC HAE Treatments Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe HAE Treatments Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe HAE Treatments Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa HAE Treatments Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa HAE Treatments Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global HAE Treatments Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global HAE Treatments Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global HAE Treatments Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global HAE Treatments Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Takeda Pharmaceuticals Basic Information, HAE Treatments Manufacturing Base, Sales Area and Its Competitors
Table 74. Takeda Pharmaceuticals HAE Treatments Product Portfolios and Specifications
Table 75. Takeda Pharmaceuticals HAE Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Takeda Pharmaceuticals Main Business
Table 77. Takeda Pharmaceuticals Latest Developments
Table 78. BioCryst Pharmaceuticals Basic Information, HAE Treatments Manufacturing Base, Sales Area and Its Competitors
Table 79. BioCryst Pharmaceuticals HAE Treatments Product Portfolios and Specifications
Table 80. BioCryst Pharmaceuticals HAE Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. BioCryst Pharmaceuticals Main Business
Table 82. BioCryst Pharmaceuticals Latest Developments
Table 83. CSL Behring Basic Information, HAE Treatments Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Behring HAE Treatments Product Portfolios and Specifications
Table 85. CSL Behring HAE Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. CSL Behring Main Business
Table 87. CSL Behring Latest Developments
Table 88. Pharming Healthcare Basic Information, HAE Treatments Manufacturing Base, Sales Area and Its Competitors
Table 89. Pharming Healthcare HAE Treatments Product Portfolios and Specifications
Table 90. Pharming Healthcare HAE Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Pharming Healthcare Main Business
Table 92. Pharming Healthcare Latest Developments
Table 1. HAE Treatments Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. HAE Treatments Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of C1 Esterase Inhibitors
Table 4. Major Players of Kallikrein Inhibitors
Table 5. Major Players of Bradykinin Receptor Antagonist
Table 6. Global HAE Treatments Sales by Type (2021-2026) & (K Units)
Table 7. Global HAE Treatments Sales Market Share by Type (2021-2026)
Table 8. Global HAE Treatments Revenue by Type (2021-2026) & ($ million)
Table 9. Global HAE Treatments Revenue Market Share by Type (2021-2026)
Table 10. Global HAE Treatments Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global HAE Treatments Sale by Application (2021-2026) & (K Units)
Table 12. Global HAE Treatments Sale Market Share by Application (2021-2026)
Table 13. Global HAE Treatments Revenue by Application (2021-2026) & ($ million)
Table 14. Global HAE Treatments Revenue Market Share by Application (2021-2026)
Table 15. Global HAE Treatments Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global HAE Treatments Sales by Company (2021-2026) & (K Units)
Table 17. Global HAE Treatments Sales Market Share by Company (2021-2026)
Table 18. Global HAE Treatments Revenue by Company (2021-2026) & ($ millions)
Table 19. Global HAE Treatments Revenue Market Share by Company (2021-2026)
Table 20. Global HAE Treatments Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers HAE Treatments Producing Area Distribution and Sales Area
Table 22. Players HAE Treatments Products Offered
Table 23. HAE Treatments Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global HAE Treatments Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global HAE Treatments Sales Market Share Geographic Region (2021-2026)
Table 28. Global HAE Treatments Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global HAE Treatments Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global HAE Treatments Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global HAE Treatments Sales Market Share by Country/Region (2021-2026)
Table 32. Global HAE Treatments Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global HAE Treatments Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas HAE Treatments Sales by Country (2021-2026) & (K Units)
Table 35. Americas HAE Treatments Sales Market Share by Country (2021-2026)
Table 36. Americas HAE Treatments Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas HAE Treatments Sales by Type (2021-2026) & (K Units)
Table 38. Americas HAE Treatments Sales by Application (2021-2026) & (K Units)
Table 39. APAC HAE Treatments Sales by Region (2021-2026) & (K Units)
Table 40. APAC HAE Treatments Sales Market Share by Region (2021-2026)
Table 41. APAC HAE Treatments Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC HAE Treatments Sales by Type (2021-2026) & (K Units)
Table 43. APAC HAE Treatments Sales by Application (2021-2026) & (K Units)
Table 44. Europe HAE Treatments Sales by Country (2021-2026) & (K Units)
Table 45. Europe HAE Treatments Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe HAE Treatments Sales by Type (2021-2026) & (K Units)
Table 47. Europe HAE Treatments Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa HAE Treatments Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa HAE Treatments Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa HAE Treatments Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa HAE Treatments Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of HAE Treatments
Table 53. Key Market Challenges & Risks of HAE Treatments
Table 54. Key Industry Trends of HAE Treatments
Table 55. HAE Treatments Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. HAE Treatments Distributors List
Table 58. HAE Treatments Customer List
Table 59. Global HAE Treatments Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global HAE Treatments Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas HAE Treatments Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas HAE Treatments Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC HAE Treatments Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC HAE Treatments Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe HAE Treatments Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe HAE Treatments Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa HAE Treatments Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa HAE Treatments Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global HAE Treatments Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global HAE Treatments Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global HAE Treatments Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global HAE Treatments Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Takeda Pharmaceuticals Basic Information, HAE Treatments Manufacturing Base, Sales Area and Its Competitors
Table 74. Takeda Pharmaceuticals HAE Treatments Product Portfolios and Specifications
Table 75. Takeda Pharmaceuticals HAE Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Takeda Pharmaceuticals Main Business
Table 77. Takeda Pharmaceuticals Latest Developments
Table 78. BioCryst Pharmaceuticals Basic Information, HAE Treatments Manufacturing Base, Sales Area and Its Competitors
Table 79. BioCryst Pharmaceuticals HAE Treatments Product Portfolios and Specifications
Table 80. BioCryst Pharmaceuticals HAE Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. BioCryst Pharmaceuticals Main Business
Table 82. BioCryst Pharmaceuticals Latest Developments
Table 83. CSL Behring Basic Information, HAE Treatments Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Behring HAE Treatments Product Portfolios and Specifications
Table 85. CSL Behring HAE Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. CSL Behring Main Business
Table 87. CSL Behring Latest Developments
Table 88. Pharming Healthcare Basic Information, HAE Treatments Manufacturing Base, Sales Area and Its Competitors
Table 89. Pharming Healthcare HAE Treatments Product Portfolios and Specifications
Table 90. Pharming Healthcare HAE Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Pharming Healthcare Main Business
Table 92. Pharming Healthcare Latest Developments
LIST OF FIGURES
Figure 1. Picture of HAE Treatments
Figure 2. HAE Treatments Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HAE Treatments Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global HAE Treatments Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. HAE Treatments Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. HAE Treatments Sales Market Share by Country/Region (2025)
Figure 10. HAE Treatments Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of C1 Esterase Inhibitors
Figure 12. Product Picture of Kallikrein Inhibitors
Figure 13. Product Picture of Bradykinin Receptor Antagonist
Figure 14. Global HAE Treatments Sales Market Share by Type in 2026
Figure 15. Global HAE Treatments Revenue Market Share by Type (2021-2026)
Figure 16. HAE Treatments Consumed in Hospital and Clinic
Figure 17. Global HAE Treatments Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 18. HAE Treatments Consumed in Pharmacy
Figure 19. Global HAE Treatments Market: Pharmacy (2021-2026) & (K Units)
Figure 20. HAE Treatments Consumed in Other
Figure 21. Global HAE Treatments Market: Other (2021-2026) & (K Units)
Figure 22. Global HAE Treatments Sale Market Share by Application (2025)
Figure 23. Global HAE Treatments Revenue Market Share by Application in 2026
Figure 24. HAE Treatments Sales by Company in 2026 (K Units)
Figure 25. Global HAE Treatments Sales Market Share by Company in 2026
Figure 26. HAE Treatments Revenue by Company in 2026 ($ millions)
Figure 27. Global HAE Treatments Revenue Market Share by Company in 2026
Figure 28. Global HAE Treatments Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global HAE Treatments Revenue Market Share by Geographic Region in 2026
Figure 30. Americas HAE Treatments Sales 2021-2026 (K Units)
Figure 31. Americas HAE Treatments Revenue 2021-2026 ($ millions)
Figure 32. APAC HAE Treatments Sales 2021-2026 (K Units)
Figure 33. APAC HAE Treatments Revenue 2021-2026 ($ millions)
Figure 34. Europe HAE Treatments Sales 2021-2026 (K Units)
Figure 35. Europe HAE Treatments Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa HAE Treatments Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa HAE Treatments Revenue 2021-2026 ($ millions)
Figure 38. Americas HAE Treatments Sales Market Share by Country in 2026
Figure 39. Americas HAE Treatments Revenue Market Share by Country (2021-2026)
Figure 40. Americas HAE Treatments Sales Market Share by Type (2021-2026)
Figure 41. Americas HAE Treatments Sales Market Share by Application (2021-2026)
Figure 42. United States HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC HAE Treatments Sales Market Share by Region in 2026
Figure 47. APAC HAE Treatments Revenue Market Share by Region (2021-2026)
Figure 48. APAC HAE Treatments Sales Market Share by Type (2021-2026)
Figure 49. APAC HAE Treatments Sales Market Share by Application (2021-2026)
Figure 50. China HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 54. India HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe HAE Treatments Sales Market Share by Country in 2026
Figure 58. Europe HAE Treatments Revenue Market Share by Country (2021-2026)
Figure 59. Europe HAE Treatments Sales Market Share by Type (2021-2026)
Figure 60. Europe HAE Treatments Sales Market Share by Application (2021-2026)
Figure 61. Germany HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 62. France HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 63. UK HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa HAE Treatments Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa HAE Treatments Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa HAE Treatments Sales Market Share by Application (2021-2026)
Figure 69. Egypt HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of HAE Treatments in 2026
Figure 75. Manufacturing Process Analysis of HAE Treatments
Figure 76. Industry Chain Structure of HAE Treatments
Figure 77. Channels of Distribution
Figure 78. Global HAE Treatments Sales Market Forecast by Region (2027-2032)
Figure 79. Global HAE Treatments Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global HAE Treatments Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global HAE Treatments Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global HAE Treatments Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global HAE Treatments Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of HAE Treatments
Figure 2. HAE Treatments Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HAE Treatments Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global HAE Treatments Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. HAE Treatments Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. HAE Treatments Sales Market Share by Country/Region (2025)
Figure 10. HAE Treatments Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of C1 Esterase Inhibitors
Figure 12. Product Picture of Kallikrein Inhibitors
Figure 13. Product Picture of Bradykinin Receptor Antagonist
Figure 14. Global HAE Treatments Sales Market Share by Type in 2026
Figure 15. Global HAE Treatments Revenue Market Share by Type (2021-2026)
Figure 16. HAE Treatments Consumed in Hospital and Clinic
Figure 17. Global HAE Treatments Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 18. HAE Treatments Consumed in Pharmacy
Figure 19. Global HAE Treatments Market: Pharmacy (2021-2026) & (K Units)
Figure 20. HAE Treatments Consumed in Other
Figure 21. Global HAE Treatments Market: Other (2021-2026) & (K Units)
Figure 22. Global HAE Treatments Sale Market Share by Application (2025)
Figure 23. Global HAE Treatments Revenue Market Share by Application in 2026
Figure 24. HAE Treatments Sales by Company in 2026 (K Units)
Figure 25. Global HAE Treatments Sales Market Share by Company in 2026
Figure 26. HAE Treatments Revenue by Company in 2026 ($ millions)
Figure 27. Global HAE Treatments Revenue Market Share by Company in 2026
Figure 28. Global HAE Treatments Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global HAE Treatments Revenue Market Share by Geographic Region in 2026
Figure 30. Americas HAE Treatments Sales 2021-2026 (K Units)
Figure 31. Americas HAE Treatments Revenue 2021-2026 ($ millions)
Figure 32. APAC HAE Treatments Sales 2021-2026 (K Units)
Figure 33. APAC HAE Treatments Revenue 2021-2026 ($ millions)
Figure 34. Europe HAE Treatments Sales 2021-2026 (K Units)
Figure 35. Europe HAE Treatments Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa HAE Treatments Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa HAE Treatments Revenue 2021-2026 ($ millions)
Figure 38. Americas HAE Treatments Sales Market Share by Country in 2026
Figure 39. Americas HAE Treatments Revenue Market Share by Country (2021-2026)
Figure 40. Americas HAE Treatments Sales Market Share by Type (2021-2026)
Figure 41. Americas HAE Treatments Sales Market Share by Application (2021-2026)
Figure 42. United States HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC HAE Treatments Sales Market Share by Region in 2026
Figure 47. APAC HAE Treatments Revenue Market Share by Region (2021-2026)
Figure 48. APAC HAE Treatments Sales Market Share by Type (2021-2026)
Figure 49. APAC HAE Treatments Sales Market Share by Application (2021-2026)
Figure 50. China HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 54. India HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe HAE Treatments Sales Market Share by Country in 2026
Figure 58. Europe HAE Treatments Revenue Market Share by Country (2021-2026)
Figure 59. Europe HAE Treatments Sales Market Share by Type (2021-2026)
Figure 60. Europe HAE Treatments Sales Market Share by Application (2021-2026)
Figure 61. Germany HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 62. France HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 63. UK HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa HAE Treatments Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa HAE Treatments Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa HAE Treatments Sales Market Share by Application (2021-2026)
Figure 69. Egypt HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries HAE Treatments Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of HAE Treatments in 2026
Figure 75. Manufacturing Process Analysis of HAE Treatments
Figure 76. Industry Chain Structure of HAE Treatments
Figure 77. Channels of Distribution
Figure 78. Global HAE Treatments Sales Market Forecast by Region (2027-2032)
Figure 79. Global HAE Treatments Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global HAE Treatments Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global HAE Treatments Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global HAE Treatments Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global HAE Treatments Revenue Market Share Forecast by Application (2027-2032)
